Kamil Slowikowski

Kamil Slowikowski

Welcome πŸ‘‹
#

I’m Kamil, a computational biologist at Mass General Brigham, where I work on genomics projects to study human immunology.

Many research labs use my single-cell data browser Cell Guide and you can see published datasets at Immunogenomics.io and Villani Lab.

I also made ggrepel, an R package for annotating figures.

πŸŽ“ Download CV

πŸ”¬ Research
#

My research is in the fields of human genetics, functional genomics, immunology, statistics, and software development. I am passionate about working closely with clinicians to advance our understanding of human immunology and disease.

In other words, I study data that tells us what cells are doing in our bodies. And I compare the cells from different people to find out what happens in diseases like rheumatoid arthritis, immunotherapy-related colitis, and COVID-19.

πŸ“š Selected Publications
#

A multimodal atlas of COVID-19 severity identifies hallmarks of dysregulated immunity
The alpha-variant wave of the COVID-19 pandemic provided a unique opportunity to study, at single-cell resolution, how near-universal exposure to the same pathogen can lead to …
Immune responses in checkpoint myocarditis across heart, blood and tumour
Immune checkpoint inhibitors are widely used anticancer therapies1 that can cause morbid and potentially fatal immune-related adverse events such as immune-related myocarditis …
Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis
CUX1 and IΞΊBΞΆ (NFKBIZ) mediate the synergistic inflammatory response to TNF and IL-17A in stromal fibroblasts
Proceedings of the National Academy of Sciences, 2020
The role of stromal fibroblasts in chronic inflammation is unfolding. In rheumatoid arthritis, leukocyte-derived cytokines TNF and IL-17A work together, activating fibroblasts to …